12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks showed significant movement. Soligenix, Longeveron, Cartesian Therapeutics, Biomerica, Allarity Therapeutics, and Envoy Medical were among the gainers, with Soligenix leading by a 95.1% increase. On the downside, Marinus Pharma, TRACON Pharma, Neumora Therapeutics, PaxMedica, Alterity Therapeutics, and SINTX Techs faced declines, with Marinus Pharma dropping by 74.5%. Biomerica's rise was attributed to its Q3 earnings release.
April 15, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Marinus Pharma's stock plummeted by 74.5% in pre-market trading, with a market value of $105.4 million.
The drastic drop in Marinus Pharma's stock price suggests negative developments or market reactions, leading to a bearish outlook in the short term. Investors may see this as a sell signal.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Biomerica's stock rose 21.98% to $1.01, following the release of its Q3 earnings, with a market cap of $16.9 million.
Biomerica's positive earnings report likely contributed to its stock price increase, indicating potential short-term growth as investors react to the financial results.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Soligenix stock surged 95.1% in pre-market trading, with a market cap of $7.9 million.
The significant pre-market surge in Soligenix's stock price indicates strong investor interest, likely driven by positive news or speculative trading. This could lead to increased volatility and potential short-term gains.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100